Evaluation of the efficacy of Chinese herbal medicine Rhizoma arisaemetis preparata in the treatment of high-risk HPV persistent infection by transvaginal administration

Obstetrics and Gynecology Hospital of Fudan University0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•The patient whose high-risk HPV screening result was positive,while after treatment, the review result was still the same type of high-risk HPV.

•1. Patients who was pregnancy, delivery or abortion within 4 weeks, gestational trophoblastic disease;
•2. Patients who used other vaginal preparations or lotions within 6 weeks before entering the clinical trial;
•3. Patients who had taken antiviral drugs orally within 6 weeks before entering the clinical trial;
•4. At present, there are other types of malignant tumor, or other malignant tumor recurrence can not be excluded;
•5. Acute phase of other diseases: disturbance of consciousness, body temperature greater than 38 degrees C vital signs instability or acute abdomen, etc.;
•6. Significant organ dysfunction: liver enzyme > 5 times normal upper limit, creatinine > 3 times normal upper limit, blood amylase > 2 times normal upper limit, cardiac function 3-4 grade, etc.;
•7. Mental illness patients receiving medication.
•8. Eliminate trichomonas, mold, Neisseria gonorrhoeae, chlamydia, mycoplasma any kind of infection.

发起方

Obstetrics and Gynecology Hospital of Fudan University